Bente-Lill Romøren
Chairman chez Farmastat AS
Profil
Bente-Lill Romøren currently works at Farmastat AS, as Chairman, Radiumhospitalets Forskningsstiftelse, as Director, and Norges Skiforbund, as Director.
Ms. Romøren also formerly worked at Novo Nordisk Scandinavia AB, as Chief Executive Officer, Photocure ASA, as Chairman, Nordic Nanovector ASA, as Director in 2013, and Circio Holding ASA, as Independent Director from 2012 to 2023.
Ms. Romøren received her graduate degree from Norwegian Institute of Technology.
Postes actifs de Bente-Lill Romøren
| Sociétés | Poste | Début |
|---|---|---|
Radiumhospitalets Forskningsstiftelse
 Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Director/Board Member | - |
| Farmastat AS | Chairman | - |
Norges Skiforbund
 Norges Skiforbund Movies/EntertainmentConsumer Services Norges Skiforbund organizes sports teams and clubs. The firm prepares skiing activity and develops top athletes. It provides combined jumping and cross country skiing, alpine skiing, freestyle, and driving. The company was founded in 1908 and is headquartered in Oslo, Norway. | Director/Board Member | - |
Anciens postes connus de Bente-Lill Romøren
| Sociétés | Poste | Fin |
|---|---|---|
| CIRCIO HOLDING ASA | Director/Board Member | 17/10/2023 |
| PHOTOCURE ASA | Chairman | - |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Chief Executive Officer | - |
| THOR MEDICAL | Director/Board Member | - |
Formation de Bente-Lill Romøren
| Norwegian Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| CIRCIO HOLDING ASA | Health Technology |
| Entreprise privées | 5 |
|---|---|
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Finance |
Norges Skiforbund
Norges Skiforbund Movies/EntertainmentConsumer Services Norges Skiforbund organizes sports teams and clubs. The firm prepares skiing activity and develops top athletes. It provides combined jumping and cross country skiing, alpine skiing, freestyle, and driving. The company was founded in 1908 and is headquartered in Oslo, Norway. | Consumer Services |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Farmastat AS |
